Clinical trial NCT06191822: Aspire2B Personalization Pilot Study Program
Official title: Aspire2B Personalization Pilot Study Program
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: App Proficiency
Behavior
Lifestyle
Keywords: Biological age
Wellness app
Lead sponsor: PepsiCo Global R&D
Sponsor class: INDUSTRY
First posted: 2024-01-05
Enrollment: 3000
Sex: ALL
Minimum age (years): 18
Maximum age (years): 75
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NON_RANDOMIZED
Intervention model: PARALLEL
Primary purpose: OTHER

Brief summary: This non-randomized pilot study program is focused on assessing the technical characteristics of the Aspire2B mobile device application.

Detailed description: Aspire2B is a mobile wellness app that uses non-invasive measurements to predict various physiological states and estimate biological age. Users are then enrolled in nutrition, fitness, or sleep challenges within the app that are aimed at improving overall wellness and thus helping to reduce biological age. Mobile health (mHealth) interventions require numerous decisions that integrate behavioral theory, user feedback, and technical and practical feasibility considerations. The main purpose of this research program is to test if the application works as intended. This pilot study program is managed internally by Pepsico clinical researchers.

Eligibility criteria: Inclusion Criteria:

* Fluent in reading and understanding English or Spanish
* Smartphone users

Exclusion Criteria:

* Cannot proceed to onboarding without downloading the app, consenting to participate, and agreeing to app Terms of Use

Primary outcomes:
measure: Assess the technical characteristics of the app (App proficiency) -Connection
timeFrame: Continuous for up to 6 weeks
measure: Assess the technical characteristics of the app (App proficiency) -Face scan age
timeFrame: Continuous for up to 6 weeks
measure: Assess the technical characteristics of the app (App proficiency) -Face scan stress
timeFrame: Continuous for up to 6 weeks
measure: Assess the technical characteristics of the app (App proficiency) -Face scan heart rate
timeFrame: Continuous for up to 6 weeks
measure: Assess the technical characteristics of the app (App proficiency) -Onboarding
timeFrame: Continuous for up to 6 weeks
measure: Assess the technical characteristics of the app (App proficiency) -Goal selection
timeFrame: Continuous for up to 6 weeks
measure: Assess the technical characteristics of the app (App proficiency) -Goal progress
timeFrame: Continuous for up to 6 weeks
measure: Assess the technical characteristics of the app (App proficiency) -Points assigned
timeFrame: Continuous for up to 6 weeks
measure: Assess the technical characteristics of the app (App proficiency) -Wellness scoring
timeFrame: Continuous for up to 6 weeks
Secondary outcomes:
measure: Learnings to inform future versions of the app -Retention
timeFrame: Continuous for up to 6 weeks
measure: Learnings to Inform future versions of the app -Overall engagement
timeFrame: Continuous for up to 6 weeks
measure: Learnings to inform changes to future versions of the app -Specific engagement
timeFrame: Continuous for up to 6 weeks
measure: Learnings to inform changes to future versions of the app - Dietary behaviors
timeFrame: Continuous for up to 6 weeks
measure: Learnings to inform changes to future versions of the app -Lifestyle behaviors
timeFrame: Continuous for up to 6 weeks
Other outcomes:
Locations:
city: Chicago
country: United States
facility: Remote, no facility visits. Managed by PepsiCo R&D Life Sciences
state: Illinois
Study officials:
affiliation: PepsiCo Global R&D
name: Tristin Brisbois, PhD, MBS
role: PRINCIPAL_INVESTIGATOR
References: